Translational Neurobiology & Drug Discovery Lab 

Contact Us
Translational Neurobiology & Drug Discovery Lab

Decoding Brain Development to Heal Children

The Translational Neurobiology & Drug Discovery Lab at Nemours Children’s in Delaware Valley examines why some children develop brain tumors and neurodevelopmental disorders. Our goal is to find new ways to treat these conditions. We look at the biological processes involved in early brain development and how genetic and molecular changes cause these processes to malfunction.

Specifically, we study the neurons in the cerebellum, the part of the brain important for movement, coordination, and behavior. By learning how cells in this area grow and connect, we gain insight into how certain brain disorders happen so we can develop better, more targeted therapies.

We drive innovation by not only studying these conditions, but we also use state-of-the-art, 3D technologies to test potential drug compounds. We have made several key advances in these areas. 

Our goal is to translate breakthrough discoveries from lab bench to patient bedside. We give hope for new treatments and a long life for kids with neurologic disease.

Principal Investigator

Sigrid A. Langhans, PhD

Sigrid A. Langhans, PhD 

Principal Research Scientist

Lab Head 

Research Areas of Focus

Doctor typing on computer

Understanding Brain Development

We use innovative models to study normal development of cerebellar granule cells. These specialized neurons are involved in movement and fine motor control as well as in behavior, learning, and memory. 

This reveals how disturbances contribute to conditions like pediatric brain tumors or neurodevelopmental disorders. It also provides insights to inform our search for targeted treatments.

Innovating Drug Discovery

In collaboration with engineers, we are creating a 3D platform for testing drugs more efficiently. This platform uses a cell culture system that mimics the brain’s extracellular matrix, or the network of molecules that surrounds and supports brain cells. 

This platform can be used with automated robots commonly used in drug discovery labs for high-throughput screening.

Accelerating Breakthrough Treatments

Our team collaborates with researchers from the early stages of project planning. We engage in joint pilot projects to support grant applications focused on high-throughput screening and chemical probe discovery. 

Our services include acquiring targets to developing assays, conducting pilot screens, and validating lead compounds.

LEARN MORE ABOUT OUR RESEARCH

ON THIS PAGE:

Recent Research Highlights

Molecular Pathways in Cerebellar Development and Maturation

Using primary neuronal cultures, organoids and transgenic mouse models, we aim at understanding the physiological function of ion transporters in cerebellar granule cell proliferation and maturation. We also study the role they play in neurodevelopmental disorders and pediatric brain tumor development.

3D Drug Screening Platforms

In an interdisciplinary approach with materials scientists, we are developing a tunable three-dimensional cell culture platform with brain-like extracellular matrix properties that is compatible with automated high-throughput screening robotics commonly found in a drug discovery lab.

High-Throughput Drug Discovery

We operate on a collaborative model encompassing early-stage project planning with investigators and joint effort pilot projects to support multi-PI grant applications focused on high-throughput screening and chemical probe discovery. Services range from target acquisition to assay development, pilot screening, and validation of lead compounds.

Research in Context

Our labs contribute to research that informs pediatric care, working in alignment with research centers and focused areas of scientific study at Nemours.